1022149-95-6Relevant articles and documents
Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease
Marco-Contelles, José,León, Rafael,De Los Ríos, Cristóbal,Samadi, Abdelouahid,Bartolini, Manuela,Andrisano, Vincenza,Huertas, Oscar,Barril, Xavier,Luque, F. Javier,Rodríguez-Franco, María I.,López, Beatriz,López, Manuela G.,García, Antonio G.,Carreiras, María Do Carmo,Villarroya, Mercedes
supporting information; experimental part, p. 2724 - 2732 (2010/02/28)
Tacripyrines (1-14) have been designed by combining an AChE inhibitor (tacrine) with a calcium antagonist such as nimodipine and are targeted to develop a multitarget therapeutic strategy to confront AD. Tacripyrines are selective and potent AChE inhibito